Esperion Therapeutics Inc. (ESPR)
Market Closed
3 Jun, 20:00
$
3. 1400
0
0%
$
650.75M Market Cap
- P/E Ratio
- Div Yield
19,624,922 Volume
-1.97 Eps
$ 3.14
Previous Close 
Want to track ESPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Esperion Therapeutics Inc. (ESPR) Statistics
Valuation metrics
Market Cap 650.75M
Enterprise value 1.19B
Trailing P/E (ttm) -28.45
Forward P/E 10.68
PEG ratio 0.08
Price/Sales (ttm) 1.92
Price/Book (mrq) -2.45
Enterprise Value/Revenue 2.85
Enterprise Value/EBITDA 15.69
Overview
Shares outstanding 245.22M
Float 255.18M
Shares short 36.43M
% Held by insiders 0.01%
% Held by institutions 0.7%
Average volume (10 days) 17.97M
Average volume (90 days) 17.09M
Price summary
52-Week low 0.91
52-Week high 4.18
Beta 0.91
50-Day moving average 2.54
200-Day moving average 2.88
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 11 Jun 2013
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.02%
Operating margin -0.08%
Operational effectiveness
Return on assets 0.12%
Return on equity 0.08%
Income Statement
Revenue (ttm) 418.24M
Revenue per share (ttm) 1.89
Quarterly revenue growth (yoy) 0.23%
Gross profit (ttm) 241.7M
EBITDA 63.87M
Net income to common (ttm) -7.42M
Diluted EPS (ttm) -0.11
Quarterly earnings growth (yoy) 1.44%
Balance Sheet
Total cash (mrq) 156.16M
Total cash per share (mrq) 0.61
Total debt (mrq) 543.81M
Total Debt/Equity (mrq) -1.8
Current ratio (mrq) 1.53%
Book value per share (mrq) -1.23
Cash Flow
Cash flow statement -18.19M
Levered free cash flow (LFCF) -49.71M
